Smith & Nephew plc (NYSE:SNN) Receives Average Rating of “Moderate Buy” from Analysts

Smith & Nephew plc (NYSE:SNN) has been given a consensus rating of “Moderate Buy” by the five research firms that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company.

A number of analysts have recently weighed in on the company. StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft assumed coverage on Smith & Nephew in a research report on Wednesday, July 24th. They issued a “buy” rating for the company.

Smith & Nephew Stock Up 0.7 %

Smith & Nephew stock opened at $29.56 on Tuesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. The stock has a market capitalization of $12.92 billion, a price-to-earnings ratio of 14.21, a PEG ratio of 1.25 and a beta of 0.82. Smith & Nephew has a 1-year low of $21.52 and a 1-year high of $31.72. The business has a fifty day moving average price of $30.37 and a 200-day moving average price of $27.53.

Institutional Trading of Smith & Nephew

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nomura Holdings Inc. acquired a new stake in Smith & Nephew during the 4th quarter worth about $887,000. Lorne Steinberg Wealth Management Inc. lifted its position in Smith & Nephew by 53.6% during the 2nd quarter. Lorne Steinberg Wealth Management Inc. now owns 231,045 shares of the medical equipment provider’s stock worth $5,725,000 after acquiring an additional 80,650 shares during the period. Clearbridge Investments LLC acquired a new stake in Smith & Nephew during the 1st quarter worth about $2,612,000. Sanctuary Advisors LLC acquired a new position in shares of Smith & Nephew in the 2nd quarter valued at about $627,000. Finally, Tocqueville Asset Management L.P. lifted its holdings in shares of Smith & Nephew by 294.9% in the 1st quarter. Tocqueville Asset Management L.P. now owns 224,441 shares of the medical equipment provider’s stock valued at $5,692,000 after buying an additional 167,599 shares during the period. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.